Abstract

Objectives: To investigate the anti-inflammatory effects of the active leflunomide metabolite A771726 (Lef-M) in combination with methotrexate (MTX) on synovial macrophages (SM) from rheumatoid arthritis (RA) patients co-cultured with an...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The HLA-DRB1*0401 Allele and the Development of Methotrexate-Induced Accelerated Rheumatoid Nodulosis
S Sohail Ahmed ... John D Reveille
Medicine | VOL. 80
S Sohail Ahmed, et. al.S Sohail Ahmed ... John D Reveille
01 Jul 2001
AB0356 Treat to target in early rheumatoid arthritis clinic (eac): remission rates on combination of leflunomide, hydroxychloroquine and methotrexate
O Semenova ... O Ogunbambi
Annals of the Rheumatic Diseases | VOL. 72
O Semenova, et. al.O Semenova ... O Ogunbambi
01 Jun 2013
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
Gerd-Rűdiger Burmester ... Udayasankar Arulmani
Annals of the Rheumatic Diseases | VOL. 74
Gerd-Rűdiger Burmester, et. al.Gerd-Rűdiger Burmester ... Udayasankar Arulmani
18 Feb 2014
SAT0100 Bone marrow OEDEMA is more associated with rapid radiographic progression than synovitis or bone erosion by using low field MRI in bio-naïve rheumatoid arthritis patients treated with adalimumab and methotrexate combination therapy
K Katayama ... T Okubo
Annals of the Rheumatic Diseases | VOL. 71
K Katayama, et. al.K Katayama ... T Okubo
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler ... Stephan Blüml
Annals of the Rheumatic Diseases | VOL. -
Markus Kieler, et. al.Markus Kieler ... Stephan Blüml
10 Jul 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
Matthew A Brown ... Irene Van Der Horst-Bruinsma
Annals of the Rheumatic Diseases | VOL. -
Matthew A Brown, et. al.Matthew A Brown ... Irene Van Der Horst-Bruinsma
08 Jul 2024
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Yusuke Yoshimura ... Naoki Sawa
Annals of the Rheumatic Diseases | VOL. -
Yusuke Yoshimura, et. al.Yusuke Yoshimura ... Naoki Sawa
04 Jul 2024
Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis
Katerina Kachler ... Aline Bozec
Annals of the Rheumatic Diseases | VOL. -
Katerina Kachler, et. al.Katerina Kachler ... Aline Bozec
04 Jul 2024
View more papers